ReciBioPharm, the Advanced Biologics division of Recipharm, has launched its new Process Analytical Technology (PAT) platform at this year’s Bio Summit.
Recipharm is a Sweden-based pharmaceutical contract development and manufacturing organisation (CDMO).
The system is designed to support real-time process analytics and intelligent biomanufacturing, aiding quality control for the life sciences sector.
Developed as part of Recipharm’s continuous manufacturing line for xRNA therapeutics, the innovative PAT platform is conceived to be mobile, modular, and smart.
This software transforms in-process raw data into actionable, real-time insights, enabling operators to optimise quality parameters immediately
The new platform centralises quality analytics on a mobile skid and integrates multiple advanced analytical technologies alongside proprietary orchestration and management software.
This software transforms in-process raw data into actionable, real-time insights, enabling operators to optimise quality parameters immediately and streamline the route from development to patient delivery.
Vikas Gupta, President of ReciBioPharm, said: "We designed the PAT platform to fundamentally shift how manufacturers approach analytical testing. It’s about putting insights directly into the hands of those running the process, optimising quality in real time, and enabling scalable, sustainable biomanufacturing."
Dubbed ‘QC on Wheels’, the platform is both vendor-agnostic and modality-flexible, built to accommodate both current and emerging analytical technologies.
Dubbed ‘QC on Wheels’, the platform is both vendor-agnostic and modality-flexible
It also features an open-source modelling library supporting machine learning, mechanistic, and hybrid models. In its current prelaunch configuration, the system can run multiple analyses simultaneously and is fully configurable to support commercial-scale manufacturing across a range of therapeutic modalities.
Aimed at both process development and full-scale commercial production, ReciBioPharm’s PAT system is designed to reduce overall process footprint, improve operational efficiency, and minimise waste — ultimately accelerating the delivery of vital medicines to patients.
